A Dose-escalation Study in Subjects With Advanced Malignancies

Clinical trial NCT01072266 · COMPLETED

Trial details

NCT number: NCT01072266
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Advanced Cancer Metastatic Cancer

Start date: 2010-01-01
Primary completion: 2012-07-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.